A Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Rupatadine Tablet in the Treatment of Allergic Rhinitis

ZHU Rong-fei,LIU Guang-hui,LIANG Jian-ping,MA Jian,HE Guang-xiang
2010-01-01
Abstract:OBJECTIVE To evaluate the efficacy and safety of rupatadine tablet in the treatment of allergic rhinitis.METHODS 240 allergic rhinitis patients were enrolled and divided into 2 groups equally in a randomized,double-blind,double-simulation,multicenter,positive-controlled study.The test group received rupatadine tablet,10 mg per day for 14 days;while the control group was given loratadine tablet,10 mg per day for 14 days.To observe and compare the efficacy and safety of these two drugs,the mean value of reduced symptom score,effective rate,adverse events and the outcome of laboratory examination were adopted respectively.RESULTS 236 patients were eligible for efficacy analysis(117 in test group and 119 in control group).The mean value of reduced symptom score were 7.20 in test group and 6.99 in control group.The effective rates were 95.73% in test group and 96.64% in control group.There was no significant difference between the two groups(P0.05);There were 86 adverse events developed in 53 patients mainly including dry mouth,dizziness,somnolence and hypodynamia(24 patients in test group and 29 patients in control group).The incidence of adverse events were no difference between the two groups(P0.05).CONCLUSION The results of the study indicate that rupatadine tablet could control the symptoms of allergic rhinitis effectively and it is well-tolerated.
What problem does this paper attempt to address?